Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps
Claire Hopkins, Martin Wagenmann, Claus Bachert, et al.
International Forum of Allergy & Rhinology (2021) Vol. 11, Iss. 7, pp. 1087-1101
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature
Marella Reale, Giuseppe Licci, Pietro Orlando, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 10, pp. 5023-5031
Closed Access | Times Cited: 9
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
Wytske J. Fokkens, Joaquim Mullol, David W. Kennedy, et al.
Allergy (2022) Vol. 78, Iss. 3, pp. 812-821
Open Access | Times Cited: 31
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy
Claus Bachert, Amber Luong, Philippe Gevaert, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2630-2641
Open Access | Times Cited: 21
Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy
George Papacharalampous, Jannis Constantinidis, G. Fotiadis, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 21
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Biological Therapy of Severe Asthma and Nasal Polyps
Agamemnon Bakakos, Florence Schleich, Petros Bakakos
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 976-976
Open Access | Times Cited: 24
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps
Larry Borish, Noah Cohen, Geoffrey Chupp, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 2, pp. 160-168
Open Access | Times Cited: 23
Clinical outcomes of dupilumab therapy in chronic rhinosinusitis with nasal polyps in a Canadian tertiary care rhinology practice
Elysia Grose, Alyssa Y. Li, John M. Lee
Allergy Asthma and Clinical Immunology (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 13
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Correlation of polyp grading scales with patient symptom scores and olfaction in chronic rhinosinusitis: a systematic review and meta-analysis
Seth S. Jeong, Tiffany Chen, Shaun A. Nguyen, et al.
Rhinology Journal (2022)
Open Access | Times Cited: 21
Management of United Airway Disease Focused on Patients With Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review
Joaquim Mullol, Miguel J. Maldonado, José A. García del Castillo, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 9, pp. 2438-2447.e9
Closed Access | Times Cited: 21
Omalizumab Treatment in Uncontrolled Asthma and CRSwNP Patients, with Previous Endoscopic Sinus Surgery, to Improve Quality of Life and Endoscopic Outcomes: a Two-Year Real-Life Study
Juan M. Solano, M. Amparo Callejón, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 10, pp. 555-566
Closed Access | Times Cited: 12
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report
Pietro Orlando, Giuseppe Licci, Donald Kuitche, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 3, pp. 1317-1324
Closed Access | Times Cited: 11
Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with Dupilumab
Andrea Ciofalo, Antonella Loperfido, Silvia Baroncelli, et al.
European Archives of Oto-Rhino-Laryngology (2024)
Closed Access | Times Cited: 4
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: A systematic review and meta-analysis
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Impact of residual ethmoidal laminae on dupilumab efficacy following endoscopic sinus surgery in patients with chronic rhinosinusitis: A STROBE analysis
N Yanagi, Teppei Takeda, Taisuke Akutsu, et al.
European Annals of Otorhinolaryngology Head and Neck Diseases (2025)
Closed Access
Impact of single versus multiple surgeries in CRSwNP patients undergoing treatment with dupilumab
Matteo Alicandri‐Ciufelli, Carla Cantaffa, Costanza Galloni, et al.
Acta Oto-Laryngologica (2025), pp. 1-7
Closed Access
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type‐2 CRSwNP Over 48 Months
Pietro Orlando, Giuseppe Licci, Gennaro Illiano, et al.
The Laryngoscope (2025)
Closed Access
Studies on Clinical Features, Mechanisms, and Management of Olfactory Dysfunction Secondary to Chronic Rhinosinusitis
Yi‐Tsen Lin, Te‐Huei Yeh
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 17
The effect of biologics in lung function and quality of life of patients with united airways disease: A systematic review
Javier Domínguez‐Ortega, Joaquim Mullol, Francisco Javier Álvarez Gutiérrez, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100174-100174
Open Access | Times Cited: 10
Treatment Strategy of Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Review of Recent Evidence
Sung‐Dong Kim, Kyu-Sup Cho
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5015-5015
Open Access | Times Cited: 9
Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach
Santiago Quirce, Borja G. Cosío, Agustı́n España, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
Nicholas J. Campion, Jonas Brugger, Aldine Tu, et al.
Journal of Otolaryngology - Head and Neck Surgery (2023) Vol. 52, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top